| |
| |
|
| Insider
Information: |
Chang Joseph Y |
| Relationship: |
Director |
| City: |
Provo |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
21,234 |
|
|
Indirect Shares
|
78,068 |
|
|
| Direct
Value |
$264,788 |
|
|
|
Indirect Value
|
$973,508 |
|
|
| Total
Shares |
99,302 |
|
|
| Total
Value |
$1,238,296 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NU Skin Enterprises Inc |
NUS |
Chief Scientific Officer |
2023-03-02 |
21,234 |
2023-03-02 |
78,068 |
Premium* |
|
|
Optimer Pharmaceuticals Inc |
OPTR |
Director |
2013-10-24 |
0 |
2013-10-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2007-02-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
92,306 |
|
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2007-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
92,306 |
|
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2007-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
94,806 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2010-05-12 |
4 |
S |
$11.75 |
$94,893 |
D/D |
(8,076) |
94,806 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2012-03-07 |
4 |
D |
$57.26 |
$22,560 |
D/D |
(394) |
95,018 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2012-12-31 |
4 |
D |
$37.05 |
$153,572 |
D/D |
(4,145) |
95,717 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2012-01-05 |
4 |
D |
$48.57 |
$201,323 |
D/D |
(4,145) |
96,200 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2010-05-12 |
4 |
OE |
$0.22 |
$3,265 |
D/D |
8,076 |
98,267 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2011-01-13 |
4 |
D |
$30.26 |
$125,428 |
D/D |
(4,145) |
98,371 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2012-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
98,700 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2013-03-04 |
4 |
D |
$41.20 |
$67,364 |
D/D |
(1,620) |
99,097 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2013-11-11 |
4 |
AS |
$111.63 |
$6,202,498 |
D/D |
(55,563) |
99,097 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
99,806 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2012-08-13 |
4 |
D |
$44.43 |
$6,931 |
D/D |
(156) |
99,862 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2012-04-25 |
4 |
S |
$60.02 |
$1,995,605 |
D/D |
(33,249) |
100,018 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2011-08-29 |
4 |
D |
$39.16 |
$5,208 |
D/D |
(133) |
100,345 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2011-05-17 |
4 |
D |
$37.30 |
$14,659 |
D/D |
(393) |
100,478 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2011-07-15 |
4 |
AS |
$40.00 |
$462,160 |
D/D |
(11,554) |
100,478 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2011-07-18 |
4 |
AS |
$40.00 |
$3,837,840 |
D/D |
(95,946) |
100,478 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2013-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
100,717 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2011-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
100,871 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
102,306 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-06-11 |
4 |
S |
$15.30 |
$52,953 |
D/D |
(3,461) |
102,306 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2010-08-31 |
4 |
D |
$26.85 |
$4,162 |
D/D |
(155) |
102,516 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2010-10-08 |
4 |
OE |
$30.00 |
$1,875,000 |
D/D |
62,500 |
102,516 |
0 |
- |
|
140 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
